In one paragraphArticle in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Christian Peter JaworekFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.ORCID https://orcid.org/0009-0007-9338-2624 Ina BühnenFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.
Peter HerhausDepartment of Internal Medicine III TUM University Hospital, Technical University of Munich, School of Medicine and Health Munich Germany.
Julia MeissnerMedicine V University of Heidelberg Heidelberg Germany.
Teresa HalbsguthDepartment of Oncology Universitätsklinikum Frankfurt, Johann Wolfgang Goethe‑Universität Frankfurt am Main Frankfurt am Main Germany.
Andrea KerkhoffMedical Clinic A, Universitätsklinikum Münster, Westfälische Wilhelms‑Universität Münster Münster Germany.
Valdete SchaubInternal Medicine VIII Universitätsklinikum Tübingen, Eberhard Karls Universität Tübingen Tübingen Germany.
Michael FuchsFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0003-3289-3272 Peter BorchmannFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0003-3782-2158 Karolin BehringerFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.
Paul Jan BröckelmannFaculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0001-9662-9900 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42813117
PMCPMC13622444
What OpenQuestion holds
Textmetadata
Read underepoch 390